Concepedia

Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease

James F. Donohue, Edward Kerwin, Sanjay Sethi, Brett Haumann, Srikanth Pendyala, Lorna Dean, Chris N. Barnes, Edmund J. Moran, Glenn Crater

Respiratory Medicine · 2019 · 38 citations · 14 references

DOI

Concepts

References

14

World Medical Association Declaration of Helsinki

JAMA · 2013 · 29.4K citations

, , +2

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

Donald P. Tashkin, Bartolomé R. Celli, Stephen Senn et al. · New England Journal of Medicine · 2008 · 2.2K citations · Full text

, , +17

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

Richard Casaburi, Donald A. Mahler, Paul Jones et al. · European Respiratory Journal · 2002 · 886 citations · Full text

, , +17

Prescribing Information

European Journal Of Haematology · 2015 · 791 citations

, , +9

Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator

Dennis E. Niewoehner, Kathryn Rice, Claudia Côté et al. · Annals of Internal Medicine · 2005 · 437 citations

, , +17